Helen E. Connor

2.3k total citations
49 papers, 2.0k citations indexed

About

Helen E. Connor is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Helen E. Connor has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Helen E. Connor's work include Neuropeptides and Animal Physiology (20 papers), Migraine and Headache Studies (15 papers) and Receptor Mechanisms and Signaling (14 papers). Helen E. Connor is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Migraine and Headache Studies (15 papers) and Receptor Mechanisms and Signaling (14 papers). Helen E. Connor collaborates with scholars based in United Kingdom, Sweden and Switzerland. Helen E. Connor's co-authors include W. Feniuk, P.P.A. Humphrey, David T. Beattie, M.J. Perren, Eric T. Whalley, A. W. Oxford, Darko Butina, D. I. C. SCOPES, M. Skingle and Andrew A. Parsons and has published in prestigious journals such as Gastroenterology, Brain and Analytical Biochemistry.

In The Last Decade

Helen E. Connor

49 papers receiving 1.9k citations

Peers

Countries citing papers authored by Helen E. Connor

Since Specialization

Citations

This map shows the geographic impact of Helen E. Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Connor more than expected).

Fields of papers citing papers by Helen E. Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Connor. The network helps show where Helen E. Connor may publish in the future.

Co-authorship network of co-authors of Helen E. Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Connor. A scholar is included among the top collaborators of Helen E. Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Connor. Helen E. Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission 2002 ·Brain ·Peter J. Goadsby, (unknown), Robin James Storer, Lars Edvinsson, Helen E. Connor	78
2	4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses 2001 ·Neuropharmacology ·Robin James Storer, Simon Akerman, Helen E. Connor, Peter J. Goadsby	15
3	Use of a Dual Firefly and Renilla Luciferase Reporter Gene Assay to Simultaneously Determine Drug Selectivity at Human Corticotrophin Releasing Hormone 1 and 2 Receptors 2000 ·Analytical Biochemistry ·Sarah J. Parsons, (unknown), Helen E. Connor, (unknown), James R. Brown, Heather Giles	23
4	The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system 1997 ·Regulatory Peptides ·(unknown), (unknown), M.J. Perren, Helen E. Connor, P. Ward, David T. Beattie	31
5	Recent developments in tachykinin NK₁receptor antagonists: prospects for the treatment of migraine headache 1995 ·Canadian Journal of Physiology and Pharmacology ·David T. Beattie, Helen E. Connor, R.M. Hagan	21
6	The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK₁ receptor antagonist 1995 ·British Journal of Pharmacology ·David T. Beattie, I.J.M. Beresford, Helen E. Connor, Fiona H. Marshall, A.B. Hawcock, R.M. Hagan, (unknown), P.J. Birch, P. Ward	56
7	Activation of sensory nerves in guinea-pig isolated basilar artery by nicotine: evidence for inhibition of trigeminal sensory neurotransmission by sumatriptan 1994 ·European Journal of Pharmacology ·Celestine T. O’Shaughnessy, Helen E. Connor	10
8	The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea‐pigs 1994 ·British Journal of Pharmacology ·David T. Beattie, Helen E. Connor	19
9	Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater 1994 ·European Journal of Pharmacology ·C.T. O'Shaughnessy, Helen E. Connor	25
10	Neurokinin‐induced changes in pial artery diameter in the anaesthetized guinea‐pig 1993 ·British Journal of Pharmacology ·David T. Beattie, Carole M. Stubbs, Helen E. Connor, W. Feniuk	25
11	Sensory nerve‐mediated relaxation of guinea‐pig isolated pulmonary artery: prejunctional modulation by α₂‐adrenoceptor agonists but not sumatriptan 1993 ·British Journal of Pharmacology ·(unknown), (unknown), C.T. O'Shaughnessy, Helen E. Connor	14
12	Neurokinin NK1 receptors mediate plasma protein extravasation in guinea-pig dura 1993 ·European Journal of Pharmacology ·Celestine T. O’Shaughnessy, Helen E. Connor	21
13	Lack of effect of sumatriptan and UK‐14,304 on capsaicin‐induced relaxation of guinea‐pig isolated basilar artery 1993 ·British Journal of Pharmacology ·C.T. O'Shaughnessy, Gareth Waldron, Helen E. Connor	21
14	Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation 1992 ·British Journal of Pharmacology ·Carole M. Stubbs, Gareth Waldron, Helen E. Connor, W. Feniuk	17
15	BMY 7378 is an agonist at 5-HT1A receptors mediating hypotension and renal sympatho-inhibition in anaesthetised cats 1991 ·European Journal of Pharmacology ·Carole M. Stubbs, Helen E. Connor, W. Feniuk	15
16	Serotonin receptors 1991 ·Trends in Cardiovascular Medicine ·Helen E. Connor, P.P.A. Humphrey, W. Feniuk	10
17	Neurogenically mediated contractions of dog basilar artery involve the release of a thromboxane-like substance 1989 ·European Journal of Pharmacology ·Helen E. Connor, Robert Edwards, W. Feniuk	4
18	5-hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation 1989 ·European Journal of Pharmacology ·Helen E. Connor, W. Feniuk, P.P.A. Humphrey	140
19	Influence of the endothelium on contractile effects of 5‐hydroxytryptamine and selective 5‐HT agonists in canine basilar artery 1989 ·British Journal of Pharmacology ·Helen E. Connor, W. Feniuk	45
20	Characterization of 5‐HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5‐HT₁‐like receptor agonist 1989 ·British Journal of Pharmacology ·Helen E. Connor, W. Feniuk, P.P.A. Humphrey	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact